Daniel C Danila

Title: The Innovative Mind of Daniel C. Danila

Introduction

Daniel C. Danila, an accomplished inventor based in New York, NY, has made significant contributions to the field of cancer research and biotechnology. With two patents to his name, his work focuses on enhancing our understanding of prostate cancer and improving therapeutic strategies.

Latest Patents

Danila's latest patents highlight innovative methods in cancer research. One of his notable inventions, "Genes Associated with Dasatinib Sensitivity," pertains to a technique for Cell Type Specific Labeling with Amino Acid Precursors (CTAP). This method allows for the incorporation of stable isotope-labeled amino acids into the proteome of vertebrate cells that have been genetically engineered to produce essential amino acids from their substrates. The advantages of this method include supporting cellular growth and enabling differential labeling of proteins within multicellular environments.

Another significant patent, "Gene Expression Profile Associated with Prostate Cancer," focuses on using an RT-PCR platform to detect gene transcripts that are highly expressed in prostate tissue. This discovery emphasizes the importance of gene expression profiles obtained from peripheral blood mononuclear cells (PBMC) in predicting overall survival in patients with metastatic castration-resistant prostate cancer (mCRPC). The innovative approach allows for identification of key genes, such as KLK3, KLK2, HOXB13, GHRL2, and FOXA1, to provide more reliable prognostic predictions.

Career Highlights

Daniel C. Danila is currently associated with the Memorial Sloan Kettering Cancer Center, a leading institution in cancer research and treatment. His work there exemplifies his commitment to advancing oncology through innovative research and patentable inventions.

Collaborations

Throughout his career, Danila has collaborated with esteemed colleagues, including Howard Scher and Martin Fleisher. These partnerships have enriched his research endeavors and have been instrumental in developing impactful methodologies that enhance cancer diagnosis and treatment.

Conclusion

Daniel C. Danila's inventive work and dedication to cancer research not only showcase his ingenuity but also significantly contribute to the ongoing efforts in understanding and combating prostate cancer. His patents offer promising methodologies that may pave the way for future advancements in oncology and personalized medicine.